ZNTL — ZENTALIS PHARMACEUTICALS INC

Ownership history in Engineers Gate Manager LP  ·  6 quarters on record

This page tracks every 13F SEC filing in which Engineers Gate Manager LP reported a position in ZENTALIS PHARMACEUTICALS INC (ZNTL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2023 Q3)
Avg. % of fund
0.01%
First filed
2023 Q3
Last filed
2025 Q3
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 13,619 +598 +4.6% 0.00% $21K $1.51
2025 Q2 REDUCED 13,021 -4,928 -27.5% 0.00% $15K $1.16
2024 Q4 ADDED 17,949 +3,312 +22.6% 0.00% $54K $3.03
2024 Q2 REDUCED 14,637 -10,975 -42.9% 0.00% $60K $4.09
2024 Q1 ADDED 25,612 +3,001 +13.3% 0.01% $404K $15.76
2023 Q3 INITIATED 22,611 — — 0.02% $454K —
% of Fund (quarterly)    ZNTL price (monthly, adj. close)

Other funds also holding ZNTL

As of 2025 Q4 — sorted by position size

5AM Venture Management, LLC 3Y 1.68% PFIZER INC 0.54% Stonepine Capital Management, LLC 3Y 7Y 0.46% Opaleye Management Inc. 3Y 7Y 0.25% Decheng Capital LLC 0.24% Almitas Capital LLC 3Y 7Y 0.18% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.14% Anfield Capital Management, LLC 3Y 0.1% Quarry LP 3Y 0.03% XTX Topco Ltd 3Y 0.02%
← Back to Engineers Gate Manager LP Holdings